Pharmacokinetics of Once-Daily IV Busulfan as Part of Pretransplantation Preparative Regimens: A Comparison with an Every 6-Hour Dosing Schedule
Authors:
- Timothy MaddenTMTimothy Madden
- Marcos de LimaMLMarcos de Lima
- Neil ThaparNTNeil Thapar
- John NguyenJNJohn Nguyen
- Soonja RobersonSRSoonja Roberson
- Daniel CourielDCDaniel Couriel
- Betty PierreBPBetty Pierre
- Elizabeth J. ShpallESElizabeth J. Shpall
- Roy B. JonesRJRoy B. Jones
- Richard E. ChamplinRCRichard E. Champlin
- Borje S. AnderssonBABorje S. Andersson
Open Access
- 1 January 2007
- journal article
- clinical trial
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 13 (1) , 56-64
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Dose modification protocol using intravenous busulfan (Busulfex) and cyclophosphamide followed by autologous or allogeneic peripheral blood stem cell transplantation in patients with hematologic malignanciesTransplantation and Cellular Therapy, 2004
- Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDSBlood, 2004
- Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosisBlood, 2004
- Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cellsBlood, 2003
- The effect of metronidazole on busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantationBone Marrow Transplantation, 2003
- Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: Study of pharmacokinetics and early clinical outcomesTransplantation and Cellular Therapy, 2002
- Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndromeBlood, 2002
- Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignanciesBone Marrow Transplantation, 2000
- Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantationCancer Chemotherapy and Pharmacology, 1989
- Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and CyclophosphamideNew England Journal of Medicine, 1983